Literature DB >> 26530505

Autonomic dysfunction in subjects at high risk for Parkinson's disease.

Inga Liepelt-Scarfone1,2, Andrea Pilotto3,4, Katharina Müller1,2, Christian Bormann1,2, Katharina Gauss1,2, Isabel Wurster1,2, Johannes Streffer5, Daniela Berg1,2.   

Abstract

Aim of this project was to evaluate autonomic dysfunction in subjects proposed to be at high risk to develop Parkinson's disease (PD) compared to control subjects and PD patients at different disease stages. Combinations of substantia nigra hyperechogenicity (SN+) assessed by transcranial ultrasound (TCS), hyposmia, lifetime prevalence of depression and mild PD-specific motor signs were used to identify subjects at high risk for motor Parkinson's disease (HR-PD). Supine and standing blood pressure (BP), hearth rate (HR), orthostatic, urinary, sexual and bowel symptoms were evaluated in HR-PD, healthy control subjects and PD patients, divided into mild and advanced stages. The study group consisted of 113 PD patients (mild PD n = 71, advanced PD, n = 42), 40 HR-PD individuals and 50 controls. Compared to controls, HR-PD subjects complained more often about urinary (p = 0.002) and bowel dysfunction (p = 0.001) and had a higher diastolic BP drop after standing (p = 0.01). The cumulative number of autonomic symptoms differentiated PD as well as HR-PD significantly from controls (p < 0.001). Advanced PD patients presented often and severe orthostatic symptoms, not significantly different from mild PD after concomitant medication correction. Our results support the presence of urinary and bowel dysfunction in subjects at high risk for motor PD. Presence and severity of orthostatic symptoms was higher during stages and increase in advanced stages, at least partly due to increase in dopaminergic and conflicting medication. Understanding the progression of non-motor aspects in PD might offer the possibility to use them as targets for disease-modifying therapies.

Entities:  

Keywords:  Autonomic; Bowel; Parkinson’s disease; Prodromal; Urinary

Mesh:

Year:  2015        PMID: 26530505     DOI: 10.1007/s00415-015-7888-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

Review 1.  Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

Authors:  Ronald B Postuma; Dag Aarsland; Paolo Barone; David J Burn; Christopher H Hawkes; Wolfgang Oertel; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

Review 2.  A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.

Authors:  Anthony E Lang
Journal:  Mov Disord       Date:  2011-04-11       Impact factor: 10.338

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Authors:  R Savica; J M Carlin; B R Grossardt; J H Bower; J E Ahlskog; D M Maraganore; A E Bharucha; W A Rocca
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

5.  Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.

Authors:  Philipp Mahlknecht; Klaus Seppi; Heike Stockner; Michael Nocker; Christoph Scherfler; Stefan Kiechl; Johann Willeit; Christoph Schmidauer; Arno Gasperi; Gregorio Rungger; Werner Poewe
Journal:  Neurodegener Dis       Date:  2013-05-18       Impact factor: 2.977

6.  Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients.

Authors:  Lucie Plomhause; Kathy Dujardin; Alain Duhamel; Marie Delliaux; Philippe Derambure; Luc Defebvre; Christelle Monaca Charley
Journal:  Sleep Med       Date:  2013-07-25       Impact factor: 3.492

7.  Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies.

Authors:  Ronald B Postuma; Jean-Francois Gagnon; Amélie Pelletier; Jacques Montplaisir
Journal:  Mov Disord       Date:  2013-03-28       Impact factor: 10.338

8.  Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Authors:  Daniela Berg; Stefanie Behnke; Klaus Seppi; Jana Godau; Stefanie Lerche; Philipp Mahlknecht; Inga Liepelt-Scarfone; Christoph Pausch; Niko Schneider; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Thomas Gasser; Werner Poewe
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

Review 9.  Cardiovascular autonomic dysfunction in Parkinson's disease.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  J Neurol Sci       Date:  2009-09-08       Impact factor: 3.181

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more
  8 in total

1.  Association between cognitive impairment and urinary dysfunction in Parkinson's disease.

Authors:  Zuzanna Tkaczynska; Andrea Pilotto; Sara Becker; Susanne Gräber-Sultan; Daniela Berg; Inga Liepelt-Scarfone
Journal:  J Neural Transm (Vienna)       Date:  2017-02-17       Impact factor: 3.575

2.  Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Authors:  Andrea Pilotto; Francesca Schiano di Cola; Enrico Premi; Roberto Grasso; Rosanna Turrone; Stefano Gipponi; Andrea Scalvini; Elisabetta Cottini; Barbara Paghera; Valentina Garibotto; Maria Cristina Rizzetti; Laura Bonanni; Barbara Borroni; Silvia Morbelli; Flavio Nobili; Ugo Paolo Guerra; Daniela Perani; Alessandro Padovani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

3.  Effects of Exercise on Non-motor Symptoms in Parkinson's Disease.

Authors:  Amy W Amara; Adeel A Memon
Journal:  Clin Ther       Date:  2017-12-01       Impact factor: 3.393

Review 4.  Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.

Authors:  Terry D Ellis; Cristina Colón-Semenza; Tamara R DeAngelis; Cathi A Thomas; Marie-Hélène Saint Hilaire; Gammon M Earhart; Leland E Dibble
Journal:  Semin Neurol       Date:  2021-03-19       Impact factor: 3.420

5.  Non-Motor Symptoms of Parkinson's Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients.

Authors:  Houyam Tibar; Khalil El Bayad; Ahmed Bouhouche; El Hachmia Ait Ben Haddou; Ali Benomar; Mohamed Yahyaoui; Abdelhamid Benazzouz; Wafa Regragui
Journal:  Front Neurol       Date:  2018-04-04       Impact factor: 4.003

6.  Prevalence of postural hypotension in primary, community and institutional care: a systematic review and meta-analysis.

Authors:  Sinead T J McDonagh; Natasha Mejzner; Christopher E Clark
Journal:  BMC Fam Pract       Date:  2021-01-02       Impact factor: 2.497

7.  Acupuncture Treatment Reduces Incidence of Parkinson's Disease in Patients With Depression: A Population-Based Retrospective Cohort Study in Taiwan.

Authors:  Cheng-Hao Huang; Mei-Chen Lin; Ching-Liang Hsieh
Journal:  Front Aging Neurosci       Date:  2020-12-04       Impact factor: 5.750

8.  Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats.

Authors:  Jie Sun; Chao He; Qiu-Xin Yan; Hong-Dan Wang; Ke-Xin Li; Xun Sun; Yan Feng; Rong-Rong Zha; Chang-Peng Cui; Xue Xiong; Shan Gao; Xue Wang; Rui-Xue Yin; Guo-Fen Qiao; Bai-Yan Li
Journal:  CNS Neurosci Ther       Date:  2021-01-21       Impact factor: 5.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.